Bacterial endotoxins in the intestines can traverse the mucosal barrier tion and enter the blood and lymphatic system and hence affect eral immune responses. Colostrum biofunctional constituents like globulins, lysozymes and lactoferrins have been reported to neutralize ns and control many of viral and bacterial infections in humans. This was done on a total of 60 male Wistar rats that were randomly assigned r groups, each comparising 15 animals: groups I, II and III in addition to trol group. Endotoxaemia was caused by administrating an oral sion of enterotoxigenic Escherichia coil (1.0x106CFU/mL) directly into duodenum of anaesthetized rats after giving intraperitoneal carrageenan. the same time, bovine colostrums and/or praline-rich polypeptide (PRP) given. Therapeutic effects were studied by examining both plasma An activity and bacterial load of both mesenterial lymph nodes and neal lavages. Results were compared with those obtained with the milk which was used in a control group. Value of plasma endotoxin activity of s I, II and were 68.1±4.3, 112.3±3.5 and 56.0±3.5 EU/dI, respectively 6 h of the infection incidence compared with the control group value 8-18.8 EU/dl. The reduction in bacterial infection of lymph nodes and eal lavages was also evident with different degrees of efficiency. The nce of bacterial infection in lavage was 42.1, 46.8, 36.3 and 64.8% in experimental groups I, ll, III and the control one respectively, whereas, the nce of lymph nodes infection was 40.2, 44`.4, 33.9 and 66.7% in the tmental groups I, II, III and the control one, respectively. Whole bovine trums and/or PRP may help to eliminate and control Escherichia coli xaemia in rats when administered into the gut in conditions of septic